Eisai Files Agreement With Generic Drugmakers

Law360, New York (October 12, 2007, 12:00 AM EDT) -- Toyko-based drug company Eisai Co. Ltd. has reached a sort of detente with generic drugmakers Mutual Pharmaceuticals Company, Inc. and United Research Laboratories Inc. in a patent dispute over the billion-dollar Alzheimer's treatment Aricept.

Judge Esther Salas signed off on the stipulation and order Wednesday, approving an agreement which says that URL/Mutual will not sell a generic product containing the active ingredient of Aricept, donepezil hydrochloride in the United States until one of three conditions occur.

Either URL/Mutual must give Eisai written notice of its intent...
To view the full article, register now.